📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Dermonecrosis caused by a spitting cobra snakebite results from toxin potentiation and is prevented by the repurposed drug varespladib (2024)

First Author: Bartlett K

Attributed to: Tropical Infectious Disease Consortium: Expanding and Accelerating Product Development funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.2315597121

PubMed Identifier: 38687786

Publication URI: http://europepmc.org/abstract/MED/38687786

Type: Journal Article/Review

Parent Publication: Proceedings of the National Academy of Sciences

Issue: 19